LIVE: Monitoring of Patients Receiving Menin Inhibitors for Acute Leukemia
LIVE WEBINAR: March 16, 2026 | 12:00pm-1:00pm ET
Registration includes the live webinar link (sent via Zoom), the webinar recording, PDF of the slides, pre- and post- knowledge check questions, and continuing education credit (CME and CMLE).
This interactive live webinar is part 22 of the Emerging and Evolving Biomarkers Series.
Description:
Menin inhibitors are targeted therapies for the treatment of genetically defined subsets of acute leukemia that led to clinical responses in refractory disease. However, as observed with other targeted therapies for cancer, on-target resistance mutations emerged in advanced cases following monotherapy. Therefore, combination strategies incorporating menin inhibitors are needed to improve durability and depth of remission.
Learning Objectives:
- To explain the mechanisms of action of menin inhibitor
- To examine diagnostic methods used to identify leukemia subsets susceptible to menin inhibition
- To design biomarker driven strategies for combination therapies
Speaker:
Ghayas C. Issa, MD, MS
The University of Texas MD Anderson Cancer Center
Moderator:
Pawel Mroz, MD, PhD
University of Minnesota Medical School
Duration: 1 Hour
Live webinar: March 16, 2026 | 12:00pm ET
How to Register:
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, create a FREE account.
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: December 31, 2028
Accreditation Statements
AMA PRA Category 1 Credit(s)™
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of American Society
for Clinical Pathology (ASCP) and Association for Molecular Pathology
(AMP). The American Society for Clinical Pathology (ASCP) is accredited
by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the
ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements
for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.